Importantly, combination with nanoPDLIM2 further significantly decreased both tumor number and tumor burden, suggesting a promising synergy between PDLIM2 nanotherapy and chemotherapy in lung cancer treatment. This evidence concerns the gene PDLIM2 and lung carcinoma.